Overview

Losartan to Improve Hip Microfracture

Status:
Terminated
Trial end date:
2020-12-04
Target enrollment:
Participant gender:
Summary
Phase I/IIA randomized, double-blind, placebo-controlled clinical trial to assess safety and efficacy of oral losartan for improving cartilage repair following microfracture to treat focal cartilage defects during hip arthroscopy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Steadman Philippon Research Institute
Collaborators:
Office of Naval Research (ONR)
United States Department of Defense
Treatments:
Losartan